首页> 美国卫生研究院文献>Neuro-Oncology >Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.
【2h】

Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.

机译:星形细胞和少突神经胶质谱系脑肿瘤的化学疗法:过去十年以及我们的发展方向。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Over the past three decades, we have made great strides in the treatment of most, but not all, brain tumors. Dramatic advances have occurred in diagnostic imaging, neurosurgery, neuroanesthesia, radiotherapy, and chemotherapy for CNS tumors. Unfortunately, our progress has not yet met our expectations. Because of the infiltrative nature of most primary brain tumors, neurosurgery can never be expected to be curative for the majority of gliomas. Because infiltrative tumors interdigitate with normal brain cells and are not highly sensitive to irradiation, one cannot expect radiotherapy to be curative without serious damage to normal brain cells. The hope for a cure, then, rests with chemotherapy. Those who administer chemotherapy to patients with CNS tumors fully expect that, in time, long-term survival and, ultimately, the cure will become an everyday reality. To achieve that reality, however, new treatment concepts and drugs are needed.
机译:在过去的三十年中,我们在大多数(但不是全部)脑肿瘤的治疗方面取得了长足的进步。在诊断,中枢神经系统肿瘤的影像学,神经外科,神经麻醉,放疗和化学疗法方面已经取得了重大进展。不幸的是,我们的进展尚未达到我们的期望。由于大多数原发性脑肿瘤具有浸润性,因此绝不能期望神经外科手术能治愈大多数神经胶质瘤。由于浸润性肿瘤与正常脑细胞相互交叉,并且对放射线不是高度敏感,因此不能指望放疗能够治愈而不会严重损害正常脑细胞。因此,治愈的希望在于化学疗法。那些对中枢神经系统肿瘤患者进行化学疗法的人完全希望,随着时间的流逝,长期生存以及最终的治愈将成为日常生活。然而,为了实现这一现实,需要新的治疗概念和药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号